Clinical trials
Phase 2 COVID-19 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 11 |
| 2021 | 14 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
| Completed | 17 |
| Withdrawn | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu Province Centers for Disease Control and Prevention | 3 |
| Livzon Pharmaceutical Group Inc. | 3 |
| CanSino Biologics Inc. | 2 |
| The University of Hong Kong | 2 |
| Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 1 |
| Ansun Biopharma, Inc. | 1 |
| AstraZeneca | 1 |
| Beijing Minhai Biotechnology Co., Ltd | 1 |
| BioNTech SE | 1 |
| Brii Biosciences Limited | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 43 |
| Coronavirus Infections | 3 |
| Pneumonia | 2 |
| Infections | 1 |
| Pneumonia, Ventilator-Associated | 1 |
| Pneumonia, Viral | 1 |
| Postoperative Complications | 1 |
| Severe Acute Respiratory Syndrome | 1 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.